Listed on
(Coverage)
JCR1997-2023
SJR1999-2020;2022-2023
CiteScore2011-2023
SCI2010-2019
SCIE2010-2024
CC2016-2024
SCOPUS2017-2024
MEDLINE2016-2024
EMBASE2016-2024
Country
USA
Aime & Scopes
Drug Metabolism and Disposition will consider for publication manuscripts describing the results of original basic and clinical research that contribute significant and novel information on the metabolism, transport, and disposition of drugs, therapeutic macromolecules, environmental chemicals and in some instances endogenous compounds. Manuscripts that describe mechanistic aspects of drug metabolism and transport as well as those examining mechanisms that affect expression and regulation of drug-metabolizing enzymes and transporters, including genetic variability, are encouraged. Manuscripts concerned with genetic, nutritional, or hormonal factors that influence the biological fate of chemicals are also of interest, as are those that address the toxicologic consequences of xenobiotic metabolism.
Manuscripts describing metabolite identification and/or identification of specific enzymes responsible for particular metabolic pathways, and manuscripts presenting the results of pharmacokinetic/pharmacodynamic studies will be considered only if they have broader impact beyond the compound(s) under study, offer new insights into important existing drugs or toxicants, or address mechanisms underlying xenobiotic disposition and response. Descriptive studies lacking such insights will not be considered for review. Authors should highlight the important aspects of such manuscripts in the cover letter and abstract.
